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European aid and health system strengthening: an analysis of donor
approaches in the DRC, Ethiopia, Uganda, Mozambique and the global fund
Lies Steurs
Centre for EU Studies, Department of Political Sciences, Ghent University, Gent, Belgium
ABSTRACT
Background: In the field of international health assistance (IHA), there is a growing consensus
on the limits of disease-specific interventions and the need for more health system strength-
ening (HSS). European donors are considered to be strong supporters of HSS. Nevertheless,
little is known about how their support for HSS translates into concrete policies at partner
country level. Furthermore, as development cooperation is a shared policy between the EU
and its Member States, it remains unclear to what extent European donors share a similar
approach.
Objective: This article reviews a PhD thesis on European aid and HSS. The thesis investigated
(1) the approaches of European donors towards IHA, and (2) the extent to which there are
similarities or differences between them. An original analytical framework was developed to
make a fine-grained analysis of European donors’ approaches in the DRC, Ethiopia, Uganda
and Mozambique. In addition, the relation of European donors with the Global Fund was
investigated.
Methods: An abductive research approach was used during which literature review, data
generation, analysis and research design mutually influenced each other. The research built
on a wide range of empirical data, including semi-structured interviews with 123 respon-
dents, policy documents and descriptive statistical analysis.
Results and conclusion: Four ‘types’ of European donors were identified, which vary in their
focus (issue-specific versus comprehensive) and their level of support to and involvement of
recipient states. Despite this heterogeneity at a specific level, there is still a general degree of
‘unity’ among European donors, especially compared with the US. Yet, there are signs that the
‘transatlantic’ divide on HSS may be converging, as European donors tend to focus more
explicitly on result-oriented approaches traditionally associated with the US and Global
Health Initiatives. Consequently, European donors play a limited role in bringing HSS more
to the forefront in IHA.
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Background
Development assistance for health (DAH) has increased
significantly since 1990. However, as can be seen in
Figure 1 the large majority of additional funding has
gone to the fight against specific diseases or themes
such as HIV/AIDS [1]. Furthermore, interventions have
often been set-up with little involvement of the state,
which led to the creation of so-called parallel systems.
Consequently, little money and attention has been dedi-
cated to strengthening the public health systems in devel-
oping countries. The lack of a well-functioning public
health system can have devastating consequences, as was
brutally demonstrated during the 2014–2016 Ebola out-
break in West Africa [2,3].
The importance of health system strengthening
(HSS) has already been acknowledged for decades,
with an important milestone being the Alma Ata
Declaration from 1978. This declaration aimed to
reach ‘health for all’ by 2000 and stressed the impor-
tance of primary healthcare and HSS to reach this
goal [4]. However, the principles of Alma Ata soon
lost prominence and donors have provided much
more attention and funding to fight specific diseases
rather than to HSS. This trend was reinforced by an
unprecedented growth of so-called Global Health
Initiatives in the beginning of the new millennium,
the most important ones being the Global Fund to
fight HIV/AIDS, Tuberculosis and Malaria (hereafter
the Global Fund), the Global Vaccines Initiative
(GAVI) and the US President’s Emergency Plan for
AIDS Relief (PEPFAR). These initiatives have mas-
sively increased the resources for global health, but
have been using rather disease-specific, parallel
approaches. Yet, since the mid-2000s, academics
and policymakers have increasingly stressed the lim-
itations of these approaches, which led to a renewed
consensus on the need for HSS.
However, despite the increased attention for HSS,
there is no common understanding on what the term
exactly entails [5,6]. Consequently, donors have different
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interpretations and use different strategies to implement
it. Moreover, the discursive importance attached to HSS
in policy documents does not necessarily translate into
increased support for HSS at country-level. Several
authors claim that HSS is often interpreted and imple-
mented in a very narrow, instrumental way, using well-
targeted and specific interventions with clear, measurable
outcomes [7–9]. This is in strong contrast to a broader
conceptualization of HSS focused on social, societal and
political dimensions.
The European Union (EU) and its Member States
have been important donors, providing about a quarter
of all DAH [1].Within their policy documents, European
donors tend to focus a lot on strengthening health sys-
tems. The Council conclusions of 2010 on the EU role in
Global health even explicitly stated that ‘the Council calls
on the EU and its Member States to act together in all
relevant internal and external policies and actions by
prioritizing their support on strengthening comprehensive
health systems in partner countries’ [10].
Nevertheless, little is known about how this
European support for HSS in policy documents trans-
lates into concrete policies at partner country-level.
Furthermore, as development cooperation is a shared
policy between the EU and its 28 Member States, it
remains unclear to what extent European donors
share a similar approach on this matter. The limited
available research on European development coopera-
tion seems to stress the differences between the indi-
vidual European donors. An often made distinction is
the one between the more progressive Nordic and
like-minded countries and the more traditional
Southern Member States [11,12]. Nevertheless,
European approaches have not been systematically
and comparatively analysed, neither in general nor
with a specific focus on the sector level.
Another related theme is the level of ‘distinctive-
ness’ or ’uniqueness’ of European donors. This relates
to the question to what extent there is – despite the
differences among them – at least some degree of
similarity among European donors, making them
different from other donors. Certainly, there are dif-
ferences with the emerging donors, which have chal-
lenged the ‘Western’ consensus on international aid
when it comes to issues such as political condition-
ality [13,14]. In addition, European donors are said to
be inspired by normative principles and they have
paid more attention to the aid effectiveness principles
than is the case for the US [15–17]. In health, in
particular, some authors referred to an Atlantic fault-
line in thinking on health systems, which is linked to
the competing public health ideologies across the
Atlantic ocean [9,18]. The US is generally considered
to be supportive of technology-oriented disease-
specific solutions, providing funding through parallel
systems and NGOs. European donors on the other
hand are considered to promote coordinated public
sector aid models, favouring sector-wide approaches
and budget support models. Yet, Storeng [9] claimed
that the transatlantic distinction is eroding in favour
of a more narrow, technology-focused and market-
based interpretation of HSS.
Building on these insights from the field of inter-
national health assistance as well as EU-Studies, the
main goal of the PhD research was to get an in-depth
understanding of the approaches on international
health assistance (IHA) of several European donors,
with a specific focus on the partner country-level.
The main research question of my dissertation was:
‘What is the European approach to international
health assistance?’ In order to answer this question, the
following sub-questions were formulated:
Figure 1. Development assistance for health, distributed by focus area (IHME, 2018).
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(1) What are the approaches of European donors
towards international health assistance?
(2) To what extent are there similarities and
differences between European donors in
this regard?
Empirical embarkation
It would have been unfeasible to research all European
donors’ health assistance approaches towards the whole
developing world through all channels and at all times.
Consequently, I had to narrow down the focus.
I analysed and compared the IHA approaches of 13
European donors in six empirical settings (Table 1). It
concerns EU itself, 10 EU Member States (France, the
UK, Belgium, the Netherlands, Sweden, Denmark,
Ireland, Italy, Spain and Germany), 1 Flanders (a feder-
ated entity of Belgium) and Switzerland.2 These are the
European donors that have financed the most DAH over
the past years. However, not all Member States’
approaches were discussed in every empirical setting.
The first setting concerns the European donors’
approaches at headquarters level. Relevant documents
and aid figures at headquarters level were discussed
to illustrate European donors’ vagueness and ambi-
guity on HSS. While certainly important, this context
was not the main focus of the PhD as it served as
a broader context for the other two, more specific
empirical contexts.
The second group of empirical settings was the
core of the PhD and concerned the bilateral coopera-
tion of European donors in four partner countries in
Sub-Saharan Africa. I focused on Sub-Saharan Africa
as this continent suffers the most from health pro-
blems and receives most DAH from (European)
donors [1]. Specifically, I examined European donors’
approaches in the DRC, Ethiopia, Uganda and
Mozambique. These countries were selected because
at least five European donors assigned health as
a priority sector of their bilateral aid in these coun-
tries. Consequently, by focusing on these four coun-
tries, a maximum amount of European donors’
approaches could be analysed. First, it could be ana-
lysed how different European donors were reacting in
the same country. Second, it could be researched how
a certain donor was behaving in different partner
countries and to what extent some general trends
about this donor’s approach can be observed across
these countries.
The last empirical setting concerned the multilateral
cooperation via the Global Fund. The EU and several of
its Member States have played an important role in the
development of the Global Fund and have been contri-
buting considerable amounts of money to it. However,
this seems to contradict with the European pleas for HSS
as the Global Fund has a disease-specific approach and
its efforts onHSS have been limited. During interviews in
the partner countries, several respondents referred to this
ambiguous relation between European donors and the
Global Fund. Consequently, I dedicated a separate article
to it [19] which was also included in the PhD
dissertation.
Methods
The research for my dissertation was conducted
through an abductive research approach. Abduction
reasons at an intermediate level between deduction
and induction [20]. Instead of following a linear ‘first
this, then that’ logic, it implies a more cyclical
research process during which literature review, data
generation, data analysis and research design
mutually influence each other [21]. Abduction stems
from the pragmatist research tradition [22] and
allowed me to conduct problem-driven and practice-
oriented research and to take a holistic perspective on
the European involvement in international health
assistance.
Empirical data were generated and analysed
through a mixture of research methods. A first
method was semi-structured expert interviewing. In
total, interviews were conducted with 123 respon-
dents. While some explorative interviews were con-
ducted at headquarters level (in 2014–2015), most of
the interviews were conducted during four fieldwork
trips in November–December 2015 (the DRC and
Ethiopia) and March–April 2017 (Uganda and
Mozambique), as well as additional Skype interviews
in early 2017 with respondents in the DRC. The
group of respondents included representatives from
Table 1. Overview of empirical settings.
EU FR UK BE FL NL SE DK IE IT ES DE CH
Headquarters x x x x x x x x x x x x x
Bilateral cooperation in partner countries DRC x x x x x
Ethiopia x x x x x x
Mozambique x x x x x x x
Uganda x x x x x x
The Global Fund x x x x x x
1As the referendum on the Brexit took place in the middle of the research and as it is not clear yet what this will imply for the development cooperation
policies of the UK and the EU, the UK is considered an EU Member State as any other in this dissertation.
2While Switzerland is not part of the EU, it was integrated in the analysis because it shares a similar history with the EU donors in the health sector of
Mozambique and because existing research suggested that Swiss development cooperation policy is relatively ‘Europeanized’ [36].
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European donor agencies, non-European donor
agencies, the Ministries of Health, civil society orga-
nizations and some local academic researchers. This
broad range of respondents allowed me to get both
internal and external perspectives on European IHA
approaches. In May–June 2017, additional interviews
were conducted over Skype to obtain more specific
information on the relations between EU donors and
the Global Fund. All interviews were recorded on
audiotaped, fully transcribed and analysed by using
NVivo software.
In addition to the interviews, policy documents
proved to be another important source of data.
A variety of documents was consulted, which
focused on the headquarters level (e.g. development
cooperation or global health strategies) or on the
specific partner countries (e.g. donors’ country-
specific development cooperation strategies, pro-
gram documents or joint evaluation documents).
Most of these documents were publicly available
on donors’ websites and other – more specific –
documents were provided by interviewees. The
documents were analysed through a close and itera-
tive reading. To complement the data from inter-
views and policy documents, I also conducted some
descriptive statistical analysis on European donors’
DAH, based on the ‘Development Assistance for
Health Database 1990–2017’ from the IHME [1].
Analytical framework
To analyse the European approaches in four partner
countries, an original analytical framework was devel-
oped. This framework built on the often-made distinc-
tion between so-called ‘vertical’ and ‘horizontal’
approaches. The vertical approach implies that funding
and attention are mainly going to disease-specific inter-
ventions, which often leads to quick, visible and measur-
able results. The horizontal approach entails a focus on
strengthening basic health care and the wider health
system. This is claimed to be more sustainable in the
long term, but it is also more abstract, as the results are
difficult to measure. The past decades have shown
a continuous debate on the advantages and disadvan-
tages of both approaches, e.g. [23–28].
However, while often used, the vertical–horizontal
dichotomy is somewhat problematic. First, the terms
are ambiguous, as they refer to a wide range of phenom-
ena [29,30]. Second, by framing the debate as
a dichotomy, one creates the impression that an IHA
approach is either ‘vertical’ or ‘horizontal’, while hybrid
approaches are also possible. To allow for a more fine-
grained analysis of the different European approaches, I,
therefore, developed a framework which exists of two
continuums (Figure 2).
The first continuum concerns the focus. This links
with the more conventional interpretations of the
vertical versus horizontal debate as being specific,
narrow and non-integrated versus comprehensive
and integrated. Given the problematic use of these
terms, I prefer to use the terms ‘issue-specific’ and
‘comprehensive’, which are the two ends of the top-
down continuum of the framework. The continuum
is divided into five separate categories:
Targeted: Particular focus on a specific disease or
health problem
Semi-targeted: Focusing on a particular disease or
health problem, but taking into account the wider
system
Hybrid: Balancing a focus on specific diseases or
health problems with a wider focus on the health
system
Semi-comprehensive: Focusing on the overall health
system, while still prioritizing certain diseases or
health problems
Comprehensive: Holistic focus on the overall health
system
The second continuum, state involvement, links to
the deeply political question to what extent donors
support the state and the existing country systems.
Although the vertical-horizontal distinction mostly
concerns the focus of IHA, some authors also use it
to denote the extent to which donors make use of
existing structures [24]. In addition, ‘the relative
power states and private sector actors should have
over the stewardship of health systems’ is also con-
sidered to be one of the major fault lines in the
debate on HSS [6]. The dimension on state invol-
vement thus refers to the extent to which donors
support governmental policies (e.g. national health
strategies), existing state structures (e.g. Ministry of
Health, national procurement systems), or even
official policymakers (e.g. members of govern-
ment). These dimensions of state involvement can
be conceptualized at both central and local levels.
The state involvement is the left-right continuum
of the framework and is divided into the following
five categories:
Parallel: Working through parallel systems without
involving the state
Semi-parallel: Working through parallel systems
while involving the state to a limited extent
Pragmatic: Involving the state to the extent possible
and consulting the governmental institutions as ‘one
of the partners’
State-supportive: Using the existing system to
a large extent and supporting the governmental insti-
tutions in developing and/or implementing its plans
State-entrusting: Entirely supporting the state
4 L. STEURS
While it may seem plausible that both dimensions cor-
relate, it is important to analytically distinguish between
them. First, this two-dimensional approach allows us to
clarify the current conceptual confusion around
a donor’s IHA approach and to make a more precise
assessment of it. Second, one could imagine that, at least
theoretically, donors have opposite approaches on both
dimensions. On the one hand, a donor could have an
issue-specific focus while at the same time closely invol-
ving the state through collaborating with the govern-
ment and the existing public health system. This would
for example be the case if a donor supports the third
country government to implement its specific HIV/
AIDS policy. On the other hand, a donor could theore-
tically have a relatively comprehensive focus which is
nevertheless implemented entirely parallel without
involving the state. This would for instance be the case
if a donor is supporting NGOs to provide primary
healthcare services, without involving the government
officials and without taking into account the existing
policies and structures.
The combination of these two continuums results
in 25 different possibilities categories. Being ideal
types, all these 25 categories are not necessarily
expected to occur in reality. Especially the categories
at the extremities are thought to be less common in
reality, as donors generally consider them to be either
undesirable (entirely targeted or parallel) or
unrealistic (entirely comprehensive or state-
entrusting). The European approaches will thus
mainly vary between the middle nine approaches.
Results and discussion
Overview of the empirical settings
The analytical framework was applied to European
donors’ health assistance in the DRC, Ethiopia,
Uganda and Mozambique. Figure 3 provides
a summary of how the analytical framework was
applied on European donors’ approaches in the four
countries. The contexts differed quite substantially,
which also impacted on donors’ approaches. In the
next paragraphs, I will provide a short summary on
the approaches in each setting.
Due to the fragile context of the DRC, high levels of
corruption and the low level of trust in the Congolese
government and structures, the existence of and discus-
sion on different approaches was the most prominently
present in this country. In principle all donors supported
the idea of HSS, but there seemed to be different inter-
pretations of it. While some donors wanted to collabo-
rate with the state institutions and work as much as
possible through the existing structure, others were
more reluctant and thought that the system had to be
built first before it could be used. These different
Figure 2. Analytical framework.
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interpretations featured prominently in the debate on the
procurement and distribution of medicines, with some
donors using the existing national system as much as
possible and others refusing to make use of it until it
proved to be working more efficiently. Overall, the
approaches of European donors varied, with Belgium
and the EU having a state-supportive approach, and the
UK, Sweden and France having a more pragmatic
approach. Also in terms of focus, approaches ranged
between semi-targeted and semi-comprehensive.
In Ethiopia, there was a relatively good relation of
trust between donors and the Federal Ministry of
Health. This was mainly due to the strong ownership
and leadership of the FMOH, which succeeded in
managing the ‘aid jungle’ by aligning the donors with
its own plans and priorities. All European donors were
contributing to the pooled MDG/SDG performance
fund. Consequently, most European donors had a state-
supportive approach. Differences in focus related to
specific objectives donors want to obtain, which can
be manifested by pushing for certain topics in discus-
sions about the MDG/SDG performance fund, but also
by funding additional-specific projects/programmes
through which a specific theme is stressed. For example,
the Netherlands focused a lot on sexual and reproduc-
tive health and rights and transferred a relatively big
amount through NGOs, in addition to the MDG/SDG
performance fund (which also resulted in a more prag-
matic approach than other donors).
In Uganda European donors used to be the strongest
supporters of the Sector Wide approach (SWAp) and
Sector Budget Support (SBS) in the late nineties and the
beginning of the 2000s, which implied a relatively com-
prehensive focus and a high level of state involvement.
However, over the years the relation between SWAp
supporters and the government started deteriorating,
due to a de-prioritization of health by the government
and increasing concerns of corruption. At the same time,
European domestic governments started to focus
increasingly on value-for-money and quick results,
which led to less commitment to the principles of the
SWAp and SBS. When a big corruption scandal at the
Office of the Prime Minister happened, all donors ended
their direct support to the government. Consequently,
the SBS in the health sector was also suspended, which
made some donors change their approach. Belgium was
the only donor that still applied a comprehensive and
state-supportive approach. Despite the fact that it also
suspended the SBS, it has implemented programmes
which aim to improve the entire health system and
which are implemented in close collaboration with the
Ministry of Health. The other European donors had
Figure 3. Summary framework.
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a more issue-specific focus with a lower level of state
involvement.
InMozambique, most European donors used to con-
tribute to the pooled fund PROSAUDE. However, over
the years PROSAUDE encountered several challenges
which led to severe discussions on its reform. However,
this reform process was hampered by other factors. Due
to a big debt scandal in 2016, donors completely lost their
trust in the government systems, which made most
donors decide to suspend all aid that was provided
directly to the government, including the funding for
PROSAUDE. In addition, the Global Financing Facility
(GFF) became an additional important initiative in the
health sector of Mozambique and was regarded by some
as an attractive alternative for PROSAUDE, given its
more specific focus on women and child’s health and
its attention for cost-effectiveness and results. The
ongoing discussions on the reform of PROSAUDE and
the launch of the GFF made clear that different positions
existed among European donors. While most donors
(Ireland, Switzerland, Denmark, Flanders and Italy) con-
tinued their support for PROSAUDE, the UK and the
Netherlands decided to stop providing funding, which
implied more issue-specific and pragmatic approaches.
On top of that, there were also clear differences in terms
of the relative importance attached to PROSAUDE, as
well as differences in focus and level of state involvement
in the complementary programmes.
As mentioned earlier, I also investigated the relation
between European donors and the Global Fund, with
a focus on the debate on HSS. This research started from
the puzzling observations during fieldwork, where inter-
viewees at European agencies complained about the
negative effects of the Global Fund on countries’ health
systems. As European donors themselves contribute sig-
nificantly to the Global Fund, I wanted to better under-
stand this relation. The findings indicated a ‘love–hate
relationship’. European donors have loved the Global
Fund’s innovative institutional set-up and its ‘saving
lives’ approach involving quick results. However, over
the years they have become more critical about the
Global Fund’s narrow focus. Consequently, they have
increasingly advocated a shift towards more HSS. This
has been partly successful at the headquarters level, most
notably the incorporation of concrete HSS commitments
in the Global Fund’s strategic documents, but challenges
at local level constrain the translation into funding and
implementation measures. The key tension is that ‘hor-
izontalizing’ the Fund remains challenging, because the
‘specificities’ that make the Global Fund so successful
and attractive, are precisely those that also impede
moves towards HSS.
As a detailed analysis of the European approaches in
each empirical setting can be found in the separate
chapters of the dissertation, I will focus in the remaining
part of this PhD review on the overall findings.
Heterogeneity among european donors
A first important finding of the PhD research was the
heterogeneity among European approaches. As can
be seen in Figure 3, individual donors’ approaches
can differ geographically and temporally. Differences
between partner countries can be seen from the dif-
ferent colours in Figure 3, which represent the four
partner countries. While several European donors
were present in the health sector in two or more
partner countries, this did not mean that they had
exactly the same approach in all settings. For exam-
ple, the UK was present in four partner countries and
its approach has been classified differently in each
country. Furthermore, differences could also be
observed over time, as can be seen from the arrows
on the summarizing framework. While the
approaches in the DRC and Ethiopia remained fairly
stable, there has been a change in approach among
some of the donors in Uganda and Mozambique over
the past years. For example, the Dutch approach in
Mozambique changed from hybrid and state-
supportive to semi-targeted and pragmatic.
However, despite these geographic and temporal
differences, certain patterns could be identified in the
approaches of each individual donor. Some donors stay
within the same ‘region’ of the framework and do not
move much. As such, their position in the framework
remains relatively stable. For example, Belgium is typi-
cally situated at the bottom right of the framework.
Some donors display a certain pattern in how they
move within the framework. For instance, a number
of countries have typically moved towards the upper left
part of the framework. Consequently, I distinguished
four ‘types’ of European donors.
Belgium, the EU, Switzerland, Spain, Denmark
and Flanders are classified as type 1, which can be
referred to as ‘hardline health system strengtheners’.
These donors were classified as either semi-
comprehensive and state-supportive or comprehen-
sive and state-supportive. The donors within this
group seem to apply this approach regardless of the
governance situation. This implies that even in
a challenging governance situation, they endeavour
to have a comprehensive focus and to have a rather
high level of state involvement.
The second type of donors is the Netherlands, Sweden
and the UK. Their approaches are in general more tar-
geted and less state-supportive than the former type of
donors. Furthermore, their approaches have also chan-
ged over time in Uganda and Mozambique.
Consequently, they can be considered to be ‘flexible’ in
the sense that the focus and level of state involvement is
likely to change in light of the governance situation of the
partner country. When there is a favourable context, this
type of donors contributes to pooled funds or sector
budget support, which implies a relatively
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comprehensive and state-supportive approach. However,
in case the context is (or becomes) less favourable, these
donors work through other partners such as NGOs and
UN agencies that are often implementing more targeted
programs. In the latter case, there is still a pragmatic level
of state involvement, but it seems to be more important
that results can be made on specific focus areas.
Ireland and Italy can be considered a third type of
donors. In general, these donors tend to be more
state-supportive than the flexible group but they
have a less profound approach on it than the hard-
liners. Furthermore, the group cannot be character-
ized by a stable focus, as donors are sometimes more
issue-specific (cf. flexible group) and sometimes more
comprehensive (cf. hardliners).
France does not belong to any of the former types, as
it is has a very particular stance. France is an important
donor to the Global Fund and GAVI and has decided to
complement its financial presence with an active pre-
sence in the policy dialogue in these organizations, both
at the level of the board and at the level of partner
countries. Within this policy dialogue, France seems to
be advocating for a more comprehensive focus and
a higher level of state involvement. While the French
approachwas only investigated in theDRC, the empirical
data on the engagement of France in the Global Fund as
well as policy documents at headquarters level and exist-
ing (grey) literature proved to be relevant additional data
to substantiate this finding.
European ‘unity’ in diversity?
The above-mentioned classification of European
donors shows that there is quite some heterogeneity
among European donors. Nevertheless, despite these
differences at the specific level, the research also
revealed that there is still a certain degree of ‘unity’
among European donors at a more general level,
which contrasts with other donors such as the US.
Consequently, while nuancing the existence of
a ‘European’ approach, this research also confirms
the transatlantic divide discussed in literature.
The relative unity among European donors and its
distinctiveness in relation to the US were prominently
discussed in the research on the Global Fund. The article
clearly showed the varying approaches on HSS between
the European donors and the US. Already in the initial
stages of the Global Fund’s development, there seemed to
be different opinions on the matter. But since the Global
Fund was thought to provide ‘complementary’ support
on top of bilateral funding, this was not considered to be
problematic at that time. However, over the years, the
Global Fund became a more powerful organization and
its targeted and parallel approach increasingly got criti-
cized. As the Global Fund appeared to have negative
effects on countries’ health systems which European
donors themselves have tried to build and strengthen,
European donors increasingly tried to ‘horizontalize’ the
Global Fund. The US on the other hand has never been
a strong advocate of broadening the approach of the
Global Fund.
The contrast between European approaches and the
US was also evidenced in the analysis of approaches in
the partner countries. Regardless of the capacity or lea-
dership of the state, European donors in general were
having a rather comprehensive focus and a relatively
high level of state involvement. In Ethiopia, Uganda
and Mozambique, European donors were the earliest
and most generous supporters of, respectively, the
MDG/SDG PF, the health SBS and PROSAUDE. In the
fragile and challenging context of the DRC, European
donors acknowledged the importance of making use of
the system as much as possible, which was manifested
most clearly in the debate on the procurement and dis-
tribution of medicines. On the other hand, the US did
not participate in any of the pooled funding arrange-
ments in Ethiopia, Uganda andMozambique. And in the
DRC, the US shared the opinion with the Global Fund
and GAVI that the national system for procurement and
distribution of medicines had to be built first before it
can be used. Consequently, the general approach of the
US can be considered to be semi-targeted and semi-
parallel. Compared to the US, all European donors’
approaches are thus located more towards the right and
bottom side of the framework.
However, this transatlantic divide also needs to be
nuanced as some degree of ‘convergence’ can be noticed
between the approaches at both sides of the Atlantic
Ocean. On the one hand, European donors seem to
have become less profound supporters of HSS in recent
years. As clarified earlier that some European donors are
more ‘flexible’ and have moved away from HSS oriented
approaches. Importantly, evenwithin the so-called ‘hard-
liners’, there are indications that HSS is increasingly
contested (e.g. in Belgium). The research on the Global
Fund also suggested that HSS may perhaps not be as
important a political priority for European donors as
often thought/pretended, as they continue supporting
the organization even though it remains questionable
whether the proclaimed efforts for more HSS can be
successful. On the other hand, the US seemed to have
opened up its approach a bit towards HSS. In all of the
partner countries, respondents of the US mentioned that
there has been a gradual shift towards a more compre-
hensive focus and a higher level of state involvement over
the years. At the same time, the recent, progressive move
of the Global Fund towards more HSS at headquarters
also implies that the US (which is a very important donor
of the Global Fund) has also agreed upon a (limited)
broadening of the approach.
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Towards an understanding of the findings
This dissertation provided an in depth analysis of
European donors’ approaches and a full explanation
went beyond the scope of the research. Nevertheless,
I can touch upon three majors factors that help to
better understand the (evolving) approaches, differ-
ences and similarities between European donors and
open avenues for further research.
First, the research clearly demonstrated the impor-
tance of partner country-related factors. In particular,
respondents often referred to the governance situation
in the partner country when discussing (certain changes
in) European donors’ approaches. The DRC and
Ethiopia could be considered to be two ‘extremes’ when
it comes to the governance situation. In the DRC, the
fragile context, the high level of corruption and the low
level of trust in the Congolese government and structures
made that none of the donors wanted to contribute to
pooled funding arrangements. In Ethiopia on the other
hand, the leadership of the Ministry of Health made that
a relatively good relation of trust existed and that
European donors have been contributing to the pooled
SDG performance fund. The governance situation of
Mozambique andUganda can be considered to be some-
where between these two extremes. In both countries,
there used to be a relatively high level of trust between
donors and the government. However, over the years, the
governance situation deteriorated. In a context in which
donors have already been struggling for years, the occur-
rence of certain corruption scandals became the decisive
moment for donors to change their approaches.
Second, the research showed the importance of
changes in international thinking on development assis-
tance the way European donors have reacted to these. In
the 1990s and early 2000s, the international development
community paid increased attention to ownership, har-
monization and alignment, which was manifested
through the development of the SWAps and the contri-
butions to pooled funds and (sector) budget support.
European donors attached great importance to the
Paris Declaration and soon became frontrunners in the
aid effectiveness agenda [31]. This has also facilitated
a certain level of unity among European donors’
approaches in IHA. As was discussed in the dissertation,
European donors were the earliest supporters of the
pooled funds and SBS in Ethiopia, Uganda and
Mozambique. By the end of the 2000s, however, the
international support for ownership, alignment and har-
monization started to wane and increasingly got ousted
by a strong focus on value-for-money and quick results
that can directly be attributed to individual donor activ-
ities and which can be easily communicated to the public
[32]. This tendency has very clearly manifested in the
health sector, where practices are being measured and
evaluated using quantitative indicators such as the
amount of bed nets provided, the amount of people
vaccinated, and – ultimately – ‘the amount of lives
saved’ [33,34]. As shown in this research, European
donors have not been immune to this international
tendency to prioritize value-for-money and quick results.
Especially in Uganda and Mozambique, donors seemed
to have lost faith in the principles of ownership, harmo-
nization and alignment, given the waning support for the
Ugandan SWAp and SBS, and the Mozambican
PROSAUDE. Several respondents were referring to the
fact that their headquarters increasingly focused on
results and accountability, which has pushed the princi-
ples of ownership, harmonization and alignmentmore to
the background. Nevertheless, this tendency to focus less
on the latter principles and more on value-for-money
and quick results appeared to be more apparent for
certain European donors than for others.
While the two above-mentioned factors certainly help
to understand why the preference for HSS among
European donors is rather fragile and ambiguous, they
fail to explain the particular differences between
European donors. Consequently, I suggest that one also
needs to investigate the domestic factors of European
donors that differ between them and can explain the
different approaches on HSS. These factors can include
(changes in) the composition of national governments,
the (lack of) roomofmanoeuvre for local delegations, the
institutional organization of development policy (and of
social and health policy), the power of national parlia-
ments and civil society organizations, economic and
foreign policy interests, etc..My research already revealed
domestic factors in Belgium, including the collaboration
between and like-mindedness among several Belgian
actors, which might explain the Belgian position as
being a hardline health system strengthener [35]. Yet,
the investigation of the domestic factors for all European
donors went beyond the scope of this research and will
need to be subject to further research.
Conclusion
The main goal of this dissertation was to get an in-depth
understanding of the IHA approaches of European
donors. The systematic, fine-grained analysis showed
that there is significant heterogeneity of European
approaches on international health assistance. Donors’
approaches differ between partner countries and they
can change over time. Yet, certain patterns can be iden-
tified that characterize individual donors. Consequently,
four ‘types’ of European donors were distinguished,
which vary in their level of support to and involvement
of recipient states and in their level of focus on specific
diseases or health issues. Despite this high level of hetero-
geneity at a specific level, the PhD research nevertheless
also showed that there is still a general degree of ‘unity’
among European donors. These distinctive similarities
become even more evident when comparing European
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donors with the US. Yet, there are signs that the ‘trans-
atlantic’ divide on the issue of health system strengthen-
ing may be converging, as several European donors are
increasingly focusing on cost-effectiveness and direct
results, which is traditionally more associated with the
US and global health initiatives.
In sum, this dissertation illustrated the heterogeneity
of European approaches and the tendency to move
away from state-supportive, comprehensive HSS
investments. Consequently, the EU as a whole seems
to play a limited role in bringing health system
strengthening more to the forefront in international
health assistance. If European donors still want to
‘walk their talk’ on HSS, they will have to reconsider
the way they are providing health assistance in fragile
governance contexts and find innovative ways to
strengthen the system. In addition, they have to
become more involved in the follow-up of multilateral
organizations both at headquarters and local level.
This research has been one of the first studies that
bridged insights from the field of EU-studies with the
field of international health assistance, by thoroughly
investigating and comparing the European IHA
approaches. Throughout the empirical research, I also
made an important analytical contribution, as
I developed a new framework to analyse donors’ IHA
approaches, which consists of two continuums being the
focus of IHA and the state involvement. The application
of the framework confirmed the relevance of the two
separate continuums. The fact that not all the donors’
approaches were classified in the diagonal from the
upper left corner to the bottom right corner illustrate
that there is no one-to-one relationship. Nevertheless, the
application of the framework also showed that in most
cases, the position of donors on both continuums seemed
relatively closely related to each other. A high level of
state involvement often involved a rather comprehensive
focus, as is the case when donors are contributing to
pooled funds or SBS. When donors have a rather prag-
matic level of state involvement, for example, when they
are channelling funding through UN agencies, this often
also implied a more targeted approach. This framework
can be further developed by focusing especially on the
relation between the two continuums.
The broad perspective on several European donors
and several empirical settings have had the downside
that not everything could be investigated in depth.
Furthermore, the focus of the research was mainly on
the donor side and less on the domestic factors in the
partner countries. Consequently, future research could
focus more in depth on one or a few European donors,
with more attention for the domestic politics and insti-
tutions which might explain the preference for a certain
approach. For example, a closer look at the UK could
be all the more relevant in the light of the Brexit. Also,
the role of post-colonial influences on donors’ DAH
could be investigated more in depth. In addition,
ethnographic research could focus more on the partner
country itself and investigate how the political, cultural,
economic, geographical and societal factors are influ-
encing the health system and the health assistance.
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Paper context
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